Generic-Drug Users Can't Pin Brand-Name Cos., NJ Court Says
A New Jersey judge dismissed allegations Tuesday from users of generic versions of the heartburn medication Reglan that the drug's brand-name manufacturers, including Wyeth LLC, misrepresented its risks, finding the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article